Search Results
Nov 04, 2025, 07:00 ET URBAN ONE, INC. REPORTS THIRD QUARTER 2025 RESULTS
SILVER SPRING, Md., Nov. 4, 2025 /PRNewswire/ -- Urban One, Inc. (NASDAQ: UONEK and UONE) today reported its results for the three months ended September 30, 2025. For the three months ended
More news about: Urban One, Inc.
Nov 04, 2025, 07:00 ET Marriott International Reports Third Quarter 2025 Results
https://news.marriott.com/static-assets/component-resources/newscenter/earnings/2025/2025-q3-earnings-infographic.pdf. BETHESDA, Md., Nov. 4, 2025 /PRNewswire/ -- Marriott International, Inc. (Nasdaq: MAR) today reported third quarter 2025 results.
More news about: Marriott International, Inc.
Nov 04, 2025, 06:52 ET Pritish Wadhwa, Stuti Rajesh Shah, and Eshan Sharma from SPJIMR, Mumbai, bagged the 'SBI Life's IdeationX 2.0 National Champion' title
collaborations. From thousands of entries, eight finalist teams advanced to the grand stage, presenting their ideas to Mr. Amit Jhingran, MD & CEO; SBI Life in the presence of an esteemed jury comprising of senior leaders from the company — Mr. M. Anand, President & Chief Distribution
More news about: SBI Life Insurance
Nov 04, 2025, 06:50 ET BD Achieves Milestone in AGILITY Study of Revello™ Vascular Covered Stent for Treatment of Peripheral Artery Disease
"This milestone reinforces the commitment of BD to advancing clinically meaningful innovation in endovascular care," said JD Meler, MD, FSIR, vice president of BD Enterprise Pre-Clinical Strategy and Medical Innovation. "The Revello™ Vascular Covered Stent is our next generation system,
More news about: BD (Becton, Dickinson and Company)
Nov 04, 2025, 06:30 ET Thomson Reuters Reports Third-Quarter 2025 Results
2026 financial framework, see pages 18-19 of the company's second-quarter management's discussion and analysis (MD&A) for the period ended June 30, 2025. The company's quarterly MD&A and annual report was filed with, or furnished to, the Canadian securities regulatory authorities and the U.S.
More news about: Thomson Reuters
Nov 04, 2025, 04:50 ET KMX INVESTOR ALERT: CarMax, Inc. Investors with Substantial Losses Have Opportunity to Lead the CarMax Class Action Lawsuit
2, 2026 to seek appointment as lead plaintiff of the CarMax class action lawsuit. Captioned Cap v. CarMax, Inc., No. 25-cv-03602 (D. Md.), the CarMax class action lawsuit charges CarMax and certain of CarMax' top executives with violations of the Securities Exchange Act of 1934.
More news about: Robbins Geller Rudman & Dowd LLP
Nov 04, 2025, 01:25 ET "Nobel Prize in Neurosurgery" Winner Dr. Aaron Cohen-Gadol Launches Revolutionary AI Platform Covering 35 Medical Specialties
https://www.atlasmeditech.com/ Media Contact:Aaron Cohen-Gadol, MD[email protected]: 317-362-8760
More news about: Atlas Meditech
Nov 03, 2025, 19:45 ET DREYER'S GRAND ICE CREAM, INC. ISSUES ALLERGY ALERT ON UNDECLARED WHEAT IN HÄAGEN-DAZS CHOCOLATE DARK CHOCOLATE MINI BARS IN 6 COUNT PACK
AR, CA, CO, GA, ID, IL, IN, KS, KY, MI, MS, MO, MT, NE, NV, NM, OH, OR, SC, TN, UT, VA, WA, WV, WI, WY) Giant Eagle: (IN, MD, OH, PA, WV)
More news about: Häagen-Dazs®
Nov 03, 2025, 19:00 ET Kaigene Enters into Exclusive Licensing Agreement with Celltrion for Novel Antibody Therapeutics in Autoimmune Diseases
through the initiation of Phase 1 study. ROCKVILLE, Md., Nov. 3, 2025 /PRNewswire/ -- Kaigene Inc., a U.S.-based biotechnology company pioneering next-generation antibody
More news about: Kaigene
Nov 03, 2025, 17:30 ET Franco-Nevada Reports Record Q3 2025 Results
information relating to these non-GAAP financial measures is incorporated by reference from the "Non-GAAP Financial Measures" section of Franco-Nevada's MD&A for the three and nine months ended September 30, 2025 dated November 3, 2025 filed with the Canadian securities regulatory authorities on SEDAR+
More news about: Franco-Nevada Corporation
Nov 03, 2025, 16:35 ET Christopher J.L. Murray Receives 2025 James and Sarah Fries Prize for Improving Health
ATLANTA, Nov. 3, 2025 /PRNewswire/ -- The CDC Foundation today announced that Christopher J.L. Murray, MD, DPhil, received the 2025 James and Sarah Fries Prize for Improving Health. Murray is honored for his pioneering work as a physician and health economist,
More news about: CDC Foundation
Nov 03, 2025, 16:05 ET AAVivo, Inc. to Present at Society for Immunotherapy of Cancer 2025
of CAR-T cells, today announced a presentation at the Society for Immunotherapy of Cancer 2025, which is being held November 5-9, in National Harbor, MD.
More news about: AAVivo, Inc.
Nov 03, 2025, 16:01 ET Shore Bancshares, Inc. Reports Quarterly Dividend of $0.12 Per Share
EASTON, Md., Nov. 3, 2025 /PRNewswire/ -- Shore Bancshares, Inc. (NASDAQ – SHBI) announced that the Board of Directors has declared a quarterly common stock dividend in the amount of $0.12
More news about: Shore Bancshares, Inc.
Nov 03, 2025, 15:13 ET Bipartisan Legislation Introduced to Expand AED Access in Transportation
legislation represents a common-sense, evidence-based investment in public health and cardiovascular emergency readiness," said Christopher M. Kramer, MD, FACC, President, American College of Cardiology. About Defibtech
More news about: Defibtech
Nov 03, 2025, 15:00 ET Dr. Max D. Schlesinger Joins OCLI Vision in Mineola and Rockville Centre
Schlesinger. "I look forward to providing the highest level of retinal care and contributing to the practice's legacy of excellence." – Max D. Schlesinger, MD Tom Burke, CEO of OCLI Vision, shared his enthusiasm for Dr. Schlesinger's arrival, stating, "We are thrilled to welcome
More news about: OCLI Vision
Nov 03, 2025, 15:00 ET Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Significantly Improves Functional Outcomes for Patients with Pulmonary Embolism
treated with CAVT plus anticoagulation returning to normalization within 48 hours compared to anticoagulation alone—a remarkable result," Rachel Rosovsky, MD, MPH, co-global principal investigator of STORM-PE RCT, hematologist at Massachusetts General Hospital and Associate Professor of Medicine at Harvard
More news about: Penumbra, Inc.
Nov 03, 2025, 14:23 ET Vascarta Inc: Transdermal Curcumin (VAS-101 Drug Candidate) Interrupts the Neuroinflammatory Pathophysiological Cascade Associated with Acute Sickle Cell Crisis
USAfLaboratory of Biochemistry and Vascular Biology, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20903, USAgDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USAhDivision
More news about: Vascarta Inc
Nov 03, 2025, 13:31 ET Recordati Rare Diseases to Share New Data at the American Society of Hematology (ASH) Meeting
Mukherjee, MD, PhD, MPH, Cleveland Clinic Poster number: 3001Title: Comprehensive analysis of subtype-specific outcomes and management in Castleman disease: a 20-year cohort studyPresenting author: Yoshito Nishimura, MD, PhD,
More news about: Recordati
Nov 03, 2025, 13:30 ET LuminoCity's 2025 Holiday Lights Festival Returns to Montgomery County with The Best Holiday Lights Experience in the DMV from Nov. 14th, 2025, to Jan. 1st, 2026
MONTGOMERY COUNTY, Md., Nov. 3, 2025 /PRNewswire/ --
More news about: LuminoCity Festival
Nov 03, 2025, 12:07 ET Inner Circle acknowledges, Michael Wilderman, MD, FACS as a Pinnacle Lifetime Member
/PRNewswire/ -- Prominently featured in The Inner Circle, Michael Wilderman, MD, FACS is acknowledged as a Pinnacle Lifetime Member for his contributions to Vascular Surgery. Dr. Michael Wilderman, MD, FACS, a renowned vascular surgeon and partner at the Bergen Vascular Institute,
More news about: The Inner Circle
Nov 03, 2025, 12:07 ET The Inner Circle acknowledges, Shlomo Shinnar, MD, Ph.D. as a Pinnacle Lifetime Member
NEW ROCHELLE, N.Y., Nov. 3, 2025 /PRNewswire/ -- Prominently featured in The Inner Circle, Shlomo Shinnar, MD, Ph.D. is acknowledged as a Pinnacle Lifetime Member for his contributions to Epilepsy Treatment and Education. Dr. Shlomo Shinnar,
More news about: The Inner Circle
Nov 03, 2025, 11:58 ET New Study Explores Placental Malperfusion's Impact on Fetal Health and Development in Congenital Heart Disease
Journal of the American College of Cardiology, the study, led by Rebecca Josowitz MD, PhD, also highlights that genetic changes in key pathways for placental and cardiac development may underlie PMP in CHD.
More news about: Children's Hospital of Philadelphia
Nov 03, 2025, 11:55 ET Endeavor Health Acquires Diamond Headache Clinic
believed migraine was a disease and had great empathy and compassion. He was a great clinician and advocate for the headache patient," said Merle Diamond, MD. "I'm very excited about our partnership with Endeavor Health and the opportunity to continue my dad's legacy and advance the quality of care for our
More news about: Endeavor Health
Nov 03, 2025, 11:36 ET Five Reasons to Be Thankful for Public Health Leaders
health professionals in every state and territory supports the health and well-being of millions of Americans every day," says ASTHO CEO Joseph Kanter, MD, MPH. "The work often happens behind the scenes, but its impact is everywhere. Whether it's responding to natural disasters or tracking emerging health
More news about: Association of State and Territorial Health Officials
Nov 03, 2025, 11:03 ET BrainXell Therapeutics Unveils Promising Preclinical Data Demonstrating Efficacy of BXT-110, an Autologous iPSC-Derived Neuronal Therapy, in Parkinson's Disease
Diego–based biotechnology company pioneering regenerative cell therapies for neurodegenerative diseases. Founded on the research of Dr. Su-Chun Zhang, MD, PhD, Advising CSO, the company's lead program, BXT-110, is advancing toward IND-enabling studies for Parkinson's disease.
More news about: BrainXell, Inc.